Home » Tenders » Americas » USA » Notice of Intent to Sole Source for the Purchase of 3D Primary Tissue Cultures Tender

Notice of Intent to Sole Source for the Purchase of 3D Primary Tissue Cultures Tender

HEALTH AND HUMAN SERVICES, DEPARTMENT OF has floated a tender for Notice of Intent to Sole Source for the Purchase of 3D Primary Tissue Cultures. The project location is USA and the tender is closing on 22 Jul 2024. The tender notice number is 24-86148, while the TOT Ref Number is 103915582. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : USA

Summary : Notice of Intent to Sole Source for the Purchase of 3D Primary Tissue Cultures

Deadline : 22 Jul 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 103915582

Document Ref. No. : 24-86148

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Tender Details

Description

The Centers for Disease Control and Prevention intends to award a sole source firm-fixed-price contract under FAR Part 13.5 procedures to MatTek Corporation for the procurement of the 3D tissue matrixes/human airway models. MatTek is the only commercial provider of ready-to-use 3D tissue matrixes of the human airway.

Service/Product Description

The purpose of this requirement is to obtain the following items on a 40-day delivery cycle:

1. Provide twelve (12) plates of qualified, ready-to-use primary human airway epithelial tissue matrixes across four (4) deliveries.

2. Provide twenty-four (24) 250mL bottles of 3 in a year.

3. Provide twenty-four (24) qualified hangtop 12-well plates in a year.

Performance Requirements

Multiple single donor/cadaver airway tissue harvests so that permissivity to seasonal and zoonotic influenza can be established with a specific donor. Ability to deliver twelve 24-well microtissue inserts (288 inserts) in a “ready-to-use” format of airway epithelium lung tissue. Ready-to-use means that the cells have already been thawed, seeded, latticed into the correct three-dimensional airway structure, and fully differentiated with beating cilia at the air-liquid-interface (ALI) and functional goblet cells producing mucin on the apical surface. Ability to deliver up to six (6) 24-well plates of microtissues (144 inserts) in a single shipment request. Delivered microtissues must pass sterility and trans-epithelial electrical resistance (TEER) tests at a rate greater than 90% 24 hours after inserts are delivered.This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) and 10 U.S.C. 3406. Interested persons may identify their interest and capability to respond to the requirement or submit quotes.

This notice of intent is not a request for competitive quotations; however, all quotations/responses ...
Active Contract Opportunity Notice ID 24-86148 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier CENTERS FOR DISEASE CONTROL AND PREVENTION Office CDC OFFICE OF ACQUISITION SERVICES
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Jul 08, 2024 10:41 am EDT
Original Response Date: Jul 22, 2024 11:00 am EDT
Inactive Policy: Manual
Original Inactive Date: Jul 23, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance: Atlanta, GA USA